Leojaponin is primarily studied for its potential anti-cancer properties. It has shown inhibitory effects on the proliferation of certain tumor cell lines, making it a subject of interest in oncology research. The compound may induce apoptosis and suppress cell cycle progression in cancer cells, particularly in studies involving liver and colon cancer models. Due to its natural origin and structural characteristics, it is also investigated for its anti-inflammatory and antioxidant activities. These properties suggest possible applications in developing chemopreventive agents or as a lead compound in pharmaceuticals targeting specific cancers. However, research remains largely preclinical, and further studies are needed to evaluate its efficacy and safety in therapeutic settings.